Mather Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14
| Closed | -$990 | – | 737 |
|
|
2025
Q1 | $990 | Buy |
14
+11
| +367% | +$778 | ﹤0.01% | 1641 |
|
|
2024
Q4 | $197 | Sell |
3
-17
| -85% | -$1.12K | ﹤0.01% | 1700 |
|
|
2024
Q3 | $1.41K | Sell |
20
-9
| -31% | -$633 | ﹤0.01% | 1526 |
|
|
2024
Q2 | $2.53K | Buy |
29
+13
| +81% | +$1.14K | ﹤0.01% | 1821 |
|
|
2024
Q1 | $1.54K | Buy |
+16
| New | +$1.54K | ﹤0.01% | 1578 |
|